Introduction
In 1987 P et al., first reported that nitric oxide (NO), a gaseous free radical, was equivalent to endothelium-derived relaxing factor 12 . Since then, many studies have been conducted elaborating the multifunctional aspects of NO in vivo and in vitro 2, 11 . This radical is generated by the action of nitric oxide synthase (NOS) and requires several cofactors, including nicotinamide adenine dinucleotide phosphate, flavin adenine dinucloetide, and flavin mononucleotide, to produce NO and L-citrulline 2 . Nitric oxide synthase enzymes can be divided into two functional classes, constitutive and inducible, based on their sensitivity to calcium. One inducible isoform of nitric oxide synthase (iNOS) and two constitutively expressed isoforms, endothelial (eNOS) and neuronal (nNOS), have been identified and cloned 11 . It has been reported that iNOS is induced in various cell types, including keratinocytes and macrophages 3 . In two recent studies, immunohistochemical techniques have been used for expression of iNOS protein in human oral epithelial dysplasia 4, 5 , an overt premalignant lesion of the human oral mucosa. Given the fact that both oral submucous fibrosis (SF) and verrucous hyperplasia (VH) are also premalignant epithelial lesions 13, 14 , we investigated the expression of iNOS protein for these two oral premalignant lesions. Furthermore, iNOS protein expression has not been reported in human oral verrucous carcinoma (VCa). Thus, the aim of the current study was to determine whether iNOS expression also occurs in SF, VH and VCa lesions of the human oral mucosa. 
Material and methods

Specimens
Immunohistochemical staining for iNOS protein
Paraffin-embedded, 4 m tissue sections from the 60 diseased and five normal buccal mucosa were stained for iNOS protein using a primary rabbit polyclonal anti-iNOS antibody obtained from Calbiochem-Novabiochem Corporation [Cat. no. 482728]. This antibody recognizes iNOS protein in humans, rats and mice and exhibits no cross-reactivities with eNOS and nNOS (information from manufacturer). Deparaffinization of all sections was performed through a series of xylene baths, with rehydration using graded alcohols. To retrieve the antigenicity, tissue sections were microwaved three times in 10 mM citrate buffer (pH 6.0) for 5 min per cycle. The sections were then immersed in methanol containing 0.3% hydrogen peroxidase for 30 min, to block endogenous peroxidase activity, and were then incubated in normal goat serum to reduce non-specific binding. Sections were incubated for 30 min at room temperature with primary antiiNOS antiserum (1:200). The sections were then processed using standard avidin-biotin immunohistochemistry, according to the manufacturer's recommendations (Vector Laboratories, Burlingame, CA, USA) 9 . Diaminobenzidine was used as a chromogen, and commercial haematoxylin was used for counterstaining. Immunohistochemical staining was classified as either negative (no staining or positive staining present for <25% of cells) or positive (>25% of cells positively stained) 4, 5 . Negative controls for the specificity of anti-iNOS antisera were included by omitting the primary antisera.
Results
Membranous staining was observed chiefly for the oral SF lesions (17/20, 85%; Fig. 1 ), whereas cytoplasmic staining was mainly determined for the VH analogues (17/20, 85%; Fig. 2 ) and VCa lesions (16/20, 80%; Fig. 3 ). Amongst those OSF specimens showing membranous staining, nuclear staining could be noted in a few cases (5/17, 30%; Fig. 1 ). Inducible NOS staining was also determined for cells of the tumour stroma, presumed to be macrophages. No iNOS activity could be detected for any of the specimens of normal buccal mucosa. Omission of the primary antisera for control sections resulted in negative iNOS-activity findings for all specimens.
Discussion
Two previous immunohistochemistrybased studies have demonstrated enhanced iNOS-protein expression for oral epithelial dysplasia, a human oral premalignant epithelial lesion 4, 5 ; however, the corresponding expression of iNOS protein has not, to the best of our knowledge, been reported previously for other analogous premalignant epithelial lesions, such as the oral SF and VH variants. In this study, we demonstrate the presence of iNOS protein in oral SF and VH lesions. Therefore, it seems reasonable to propose that the escalated iNOS-protein activity may be associated with the risk for these two types of human oral premalignant epithelial lesions. Notably, normal human hepatocytes, under the influence of high NO levels, trigger a series of events that rapidly induce both nuclear and mitochondral DNA damage, subsequently leading to cell-cycle arrest and mitochondral dysfunction, and ultimately associated with the development of hepatocellular carcinoma 8 . From immunohistochemical extrapolation, therefore, it is postulated that prolonged NO exposure for human oral keratinocytes, as revealed in this report from the enhanced iNOS activity demonstrated for oral SF and VH lesions, may contribute to the malignant transformation of these two human oral premalignant epithelial lesions.
It has been demonstrated that intensive iNOS activation and NO overproduction in tumour cells may induce apoptosis and suppress tumour growth 15, 16 , whereas low levels of NO may do the opposite 1, 15 . This leads to the question of how high NO levels in the oral SF and VH lesions may promote malignant transformation. However, immunostaining intensity of iNOS in Fig. 1 . Membranous staining for iNOS protein was predominantly observed in the lower portion of the epithelium of a representative section of oral submucous fibrosis with occasional positive staining of the keratin layer. Noting that nuclear staining is seen in some areas of the epithelium (ABC stain 100).
paraffin embedded tissue is quite variable and the intensity of staining is unable to quantify protein expression. Subsequent study on iNOS mRNA levels for lesions of OSF, VH and VCa using semi-quantitative reverse transcription polymerase chain reaction may provide a possible answer to this question.
It has been suggested that inducible NOS protein may be an immunohistochemical marker for malignant neoplasia of the prostate 10 . After about 2 years follow-up, four out of seventeen cases (24%) of verrucous hyperplasia showing iNOS positive staining have undergone malignant transformation to develop squamous cell carcinomas. On the other hand, two out of 16 cases (13%) of verrucous carcinoma showing iNOS positivity had recurred after treatment. These preliminary data suggest that iNOS expression may be a useful predictor of the outcome of oral (pre) cancer lesions. Further studies on the characteristics of iNOS-positive cells and more long-term clinical follow-up data are necessary before a confirmative conclusion and possible clinical application can be made.
The staining pattern for oral VH lesions is compatible with that for oral VCa analogues. By contrast, membranous staining was revealed predominantly for oral SF. The reasons for this difference in staining pattern are not clear. The results for iNOS staining of oral VCa in the current study are consistent with earlier investigations by B et al. 6, 7 . Furthermore, to the best of our knowledge, this is the first report identifying iNOS protein expression for lesions of oral VCa.
In conclusion, the present immunohistochemical study has demonstrated iNOS protein expression for a number of oral SF, VH and VCa lesions, compared with a lack of expression for samples from normal buccal mucosa. This suggests that iNOS protein expression is chiefly demonstrated for a subset of oral (pre)cancerous tissues, and, that an NOS-dependent mechanism may be involved in the malignant carcinogenesis of these oral epithelial (pre)malignant lesions. 
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